Elsevier

Clinica Chimica Acta

Volume 60, Issue 2, 16 April 1975, Pages 143-145
Clinica Chimica Acta

Oligosaccharides in urine of patients with glycoprotein storage diseases: I. Rapid detection by thin-layer chromatography

https://doi.org/10.1016/0009-8981(75)90119-9Get rights and content

Abstract

Thin-layer chromatography of urinary oligosaccharides was undertaken in patients affected with various glycoprotein storage diseases and showed the presence of compounds characteristic for each disease.

References (12)

  • B. Kjellman et al.

    J. Pediatr.

    (1969)
  • P. Durand et al.

    Lancet

    (1968)
  • P.A. Ockerman

    J. Pediatr.

    (1969)
  • J. Palo et al.

    J. Chromatogr.

    (1972)
  • L.S. Wolfe et al.

    J. Biol. Chem.

    (1974)
  • N.E. Norden et al.

    J. Biol. Chem.

    (1973)
There are more references available in the full text version of this article.

Cited by (150)

  • Free sialic acid storage disorder: Progress and promise

    2021, Neuroscience Letters
    Citation Excerpt :

    The FSASD diagnosis was historically confirmed by demonstrating lysosomal (rather than cytoplasmic) localization of elevated free sialic acid in cultured cells [3,18,50], but is now mostly confirmed by genetic testing detecting bi-allelic SLC17A5 mutations [1–3,9,11]. Although well-established analytic methods to determine free and/or bound sialic acid exist, including colorimetric and fluorometric analysis (thiobarbituric acid assay) [51], 1H-NMR spectroscopy [52], thin-layer chromatography [53,54], high performance anion-exchange chromatography with pulsed amperometric detection (HPAE-PAD) [55], and liquid chromatography mass spectrometry (LC/MS) [53,56], there is a lack of routine screening for urinary free sialic acid. This contributes to the considerable diagnostic delay for individuals with FSASD [11].

  • Multigene panel next generation sequencing in a patient with cherry red macular spot: Identification of two novel mutations in NEU1 gene causing sialidosis type I associated with mild to unspecific biochemical and enzymatic findings

    2017, Molecular Genetics and Metabolism Reports
    Citation Excerpt :

    Diagnosis was eventually established through multigene panel next generation sequencing of genes associated to lysosomal storage diseases. Thin-layer-chromatography was performed as previously described [1,5]. Brief, spontaneous urines were normalized to creatinine and applied to silicagel 60 plate (10 cm × 20 cm; Merck KGaA, Darmstadt, Germany).

  • Lysosomal storage disorders affecting the heart: a review

    2019, Cardiovascular Pathology
    Citation Excerpt :

    This method assesses the amount of hexuronic acid contained in the extracted GAGs and can give false-negative results when the accumulated GAG is keratin sulfate, which contains galactose instead of hexuronic acid; in this case, the diagnosis of Morquio disease may be missed [57]. The development of tandem mass spectrometry for the identification and quantification of lysosomal substrates and metabolites has been a significant advance in the diagnosis of LSDs [59,60]. In almost all cases, glycosphingolipids and oligosaccharides analyzed by this method have been shown to differ significantly in controls and affected patients [57,59].

  • Free sialic acid storage disease

    2023, Frontiers in Lysosomal Storage Diseases (LSD) Treatments
View all citing articles on Scopus
View full text